Seonix Bio is a biotechnology company that provides genetic risk prediction information to eye health professionals and researchers.
Seonix Bio has raised $748K in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in July 2025.
Seonix Bio's investors include South Australian Venture Capital Fund, Business.gov.au, Government of South Australia.
Seonix Bio is headquartered in Adelaide, Australia.
Seonix Bio is a biotechnology company that provides genetic risk prediction information to eye health professionals and researchers.
Seonix Bio is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Seonix Bio — Funding & Investors." VCBacked, July 30, 2025, https://www.vcbacked.co/company/seonix-bio. Accessed September 30, 2026.
VCBacked. (2025). Seonix Bio — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/seonix-bio
{{cite web |title=Seonix Bio — Funding & Investors |url=https://www.vcbacked.co/company/seonix-bio |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated